Showing 13,681 - 13,700 results of 105,792 for search '(( 2 de decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.74s Refine Results
  1. 13681

    Data_Sheet_5_Microbial Community Response to a Novel Salmon Resource Subsidy.pdf by Courtney E. Larson (8278182)

    Published 2020
    “…<p>Salmon decomposition is traditionally viewed through the lens of energy and nutrient subsidies, but not as a potential “microbial subsidy.” Microbial communities residing on and within spawning salmon are directly introduced into streams after host death. …”
  2. 13682

    Table_5_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…High-risk drinking was defined as 7 or more drinks for men and 5 or more for women, twice weekly. Half of the high-risk drinkers were smokers, decreasing in men but stable at 20% for women.…”
  3. 13683
  4. 13684
  5. 13685

    V2a interneurons subdivisions are differentially distributed along the rostrocaudal axis of the spinal cord. by Cédric Francius (443799)

    Published 2013
    “…<p>(AA″) Immunofluorescence labeling on transverse section at brachial levels of e12.5 embryonic spinal cord shows that V2a interneurons subdivide into medial and lateral groups (arrows). …”
  6. 13686

    Data_Sheet_1_Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence.pdf by Lavanya Visvabharathy (797665)

    Published 2022
    “…The patient was prescribed nirmatrelvir/ritonavir to treat SARS-CoV-2 persistence at 3.5 months post-acute infection and observed a reduction in PASC symptoms 3 weeks after completing antiviral treatment. …”
  7. 13687

    Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease by Minhee Kim (1592440)

    Published 2020
    “…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
  8. 13688
  9. 13689
  10. 13690

    S5 Fig - by Monica Sueiro-Olivares (5785451)

    Published 2021
    “…<b>(c)</b> Lungs of leukopenic mice infected with the <i>ΔmecB</i> mutant showed a decreased fungal burden compared to wild type infected (<i>P</i> = 0.03), unpaired 2-tailed <i>t</i> test with Welch correction) (<i>n</i> = 5, 3 technical replicates per qPCR). …”
  11. 13691
  12. 13692
  13. 13693
  14. 13694
  15. 13695

    Fig 5 - by Laura H. Spencer (14025963)

    Published 2024
    “…<p>Expression profiles of co-expressed gene modules that correlated with pCO<sub>2</sub> treatment negatively (purple, a-h) and positively (green, i-n), indicating those genes that decreased and increased with OA severity, respectively, where 370 μatm is ambient (pH 8.0), 700 μatm is moderate OA (pH 7.8), and 1400 μatm is severe OA (pH 7.5). …”
  16. 13696
  17. 13697

    A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients by Takanori Watanabe (2159686)

    Published 2019
    “…The mean period of wig use was 12.5 months. However, a few patients were still using wigs 5 years after completing chemotherapy.…”
  18. 13698
  19. 13699
  20. 13700